LOR
Reactivité: Humain
Hôte: Synthetic
BP, IHC, WB
N° du produit ABIN979528
Aperçu rapide pour Loricrin (LOR) Peptide (ABIN979528)
Antigène
LOR
(Loricrin (LOR))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
Attributs du produit
This is a synthetic peptide designed for use in combination with anti-LOR antibody (Catalog #: ARP41738_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
LOR
Reactivité: Mammifères
Hôte: Synthetic
BP, IHC, WB
Indications d'application
Each Investigator should determine their own optimal working dilution for specific applications.
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Concentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Conseil sur la manipulation
Avoid repeated freeze-thaw cycles.
Stock
-20 °C
Stockage commentaire
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Antigène
LOR
(Loricrin (LOR))
Classe de substances
Chemical
Sujet
LOR is a major protein component of the cornified cell envelope found in terminally differentiated epidermal cells. Mutations in this gene are associated with Vohwinkel's syndrome and progressive symmetric erythrokeratoderma, both inherited skin diseases.LOR encodes loricrin, a major protein component of the cornified cell envelope found in terminally differentiated epidermal cells. Mutations in LOR may be the cause of both Vohwinkel's syndrome and progressive symmetric erythrokeratoderma, both inherited skin diseases.
Alias Symbols: MGC111513
Protein Interaction Partner: EVPL,SPRR3,VIM,CSTA,IVL,KRT1,LOR,PI3,VIM